Inhaled nitric oxide reduces human lung allograft dysfunction Hiroshi Date, MD, Anastosios N. Triantafillou, MD, Elbert P. Trulock, MD, Mary S. Pohl, RN, BSN, Joel D. Cooper, MD, G.Alexander Patterson, MD The Journal of Thoracic and Cardiovascular Surgery Volume 111, Issue 5, Pages 913-919 (May 1996) DOI: 10.1016/S0022-5223(96)70364-1 Copyright © 1996 Mosby, Inc. Terms and Conditions
Fig. 1 Pao2/Fio2 ratio before (BL, baseline) and after nitric oxide treatment. Statistical analysis was performed on the data obtained during the first 8 hours because of the different durations of nitric oxide (NO) therapy in each case. *p < 0.05, **p < 0.01 (versus baseline). The Journal of Thoracic and Cardiovascular Surgery 1996 111, 913-919DOI: (10.1016/S0022-5223(96)70364-1) Copyright © 1996 Mosby, Inc. Terms and Conditions
Fig. 2 Mean pulmonary artery (PA) pressure before (BL, baseline) and after nitric oxide (NO) treatment. Statistical analysis was performed on the data obtained during the first 8 hours because of the different durations of nitric oxide therapy in each case. *p < 0.05 (versus baseline). The Journal of Thoracic and Cardiovascular Surgery 1996 111, 913-919DOI: (10.1016/S0022-5223(96)70364-1) Copyright © 1996 Mosby, Inc. Terms and Conditions